This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2005-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2007
Title: Edward A Boyd: Innovator in Anti-Apoptotic Compositions
Introduction
Edward A Boyd is a notable inventor based in Didcot, Oxon, GB. He has made significant contributions to the field of biochemistry, particularly in the development of anti-apoptotic compositions. With a total of 2 patents to his name, Boyd's work has the potential to impact various therapeutic applications.
Latest Patents
Boyd's latest patents focus on compositions containing lysophosphatidic acids that inhibit apoptosis. The first patent provides anti-apoptotic compositions containing lysophosphatidic acids and methods for making and using these compositions. These compositions may also include LPA potentiating agents, such as proteins, lipid membrane structures, and polymers like polyethylene glycols. Additionally, they can contain other pharmaceutically effective agents, including drugs, antibiotics, wound healing agents, and antioxidants. The second patent mirrors the first, emphasizing the same innovative approaches to creating effective anti-apoptotic compositions.
Career Highlights
Throughout his career, Edward A Boyd has demonstrated a commitment to advancing scientific knowledge and therapeutic solutions. His innovative work in the field of biochemistry has garnered attention and respect from peers and industry professionals alike.
Collaborations
Boyd has collaborated with notable individuals in his field, including John G Goddard and Donald H Picker. These collaborations have likely contributed to the development and refinement of his patented inventions.
Conclusion
Edward A Boyd's contributions to the field of anti-apoptotic compositions highlight his innovative spirit and dedication to improving therapeutic options. His work continues to pave the way for advancements in biochemistry and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile